Evidence map›Paper›PMID 35677669›Full record

ArticleBioImpacts : BI2022

Expression of functional eGFP-fused antigen-binding fragment of ranibizumab in

Shirin Movaghar Asareh, Tahereh Savei, Sareh Arjmand, Seyed Omid Ranaei Siadat, Fataneh Fatemi, Mehrab Pourmadadi, Javad Shabani Shayeh

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioImpacts : BI, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shirin Movaghar AsarehProtein Research Center, Shahid Beheshti University, Tehran, Iran.ORCID https://orcid.org/0000-0002-4586-414X
Tahereh SaveiProtein Research Center, Shahid Beheshti University, Tehran, Iran.ORCID https://orcid.org/0000-0002-3184-0526
Sareh ArjmandProtein Research Center, Shahid Beheshti University, Tehran, Iran.ORCID https://orcid.org/0000-0002-4225-5891
Seyed Omid Ranaei SiadatProtein Research Center, Shahid Beheshti University, Tehran, Iran.ORCID https://orcid.org/0000-0002-6466-0222
Fataneh FatemiProtein Research Center, Shahid Beheshti University, Tehran, Iran.
Mehrab PourmadadiProtein Research Center, Shahid Beheshti University, Tehran, Iran.
Javad Shabani ShayehProtein Research Center, Shahid Beheshti University, Tehran, Iran.
Shahid Beheshti University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

eGFPFab fragmentPichia pastorisRanibizumabSplit reporterVEGF-A

Identifiers

PMID35677669
PMCPMC9124873
OpenAlexW3209586724

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.